Dr. Reddy's Laboratories Ltd (RDY) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Dr. Reddy's Laboratories Ltd (RDY), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Dr. Reddy's Laboratories Ltd, analysts forecast revenue rising from INR 277.32B in 2024 to INR 439.31B in 2029; the average estimate for 2029 earnings per share is INR 73.81; with published estimates ranging from INR 71.36 to INR 79.00; 19 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (INR)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast (INR)
Dr. Reddy's Laboratories Ltd (RDY) forecast — frequently asked questions
What is the analyst price target for Dr. Reddy's Laboratories Ltd?
Analysts covering Dr. Reddy's Laboratories Ltd (RDY) have a consensus price target of $14.35, 3.0% below the current price of $14.79. Published targets range from $13.90 to $14.80. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Dr. Reddy's Laboratories Ltd's earnings?
The average analyst estimate for Dr. Reddy's Laboratories Ltd (RDY) earnings per share in 2029 is 73.81, with individual estimates between 71.36 and 79.00.
How much revenue is Dr. Reddy's Laboratories Ltd expected to make?
Analysts forecast Dr. Reddy's Laboratories Ltd (RDY) revenue of INR 439.31B in 2029, based on 9 published estimates.
How many analysts cover RDY?
19 analysts contribute estimates for Dr. Reddy's Laboratories Ltd (RDY). Thin coverage makes an average less reliable.
Analyst forecasts for other Drug Manufacturers - Specialty & Generic stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.